Trial intelligence / Profile preview

Interaction of Echinacea, Ginkgo, or Ginseng with Lopinavir/Ritonavir

NCT00103012Phase 4Completed

Sponsor
National Institutes of Health
Start
Jan 2005
Primary completion
Jan 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of lopinavir in human immunodeficiency virus infection (HIV), sponsored by National Institutes of Health. Started Jan 2005; status: completed.

02

Drugs

lopinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00103012.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00103012.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call